Noted

• Eli Lilly and Company and Beijing, China's Innovent Biologics announced that they will collaborate on the development and potential commercialization of at least three cancer treatments over the next decade. The collaboration will include Lilly's cMet monoclonal antibody (mAb) for possible treatment of non–small cell lung cancer and Innovent's mAb targeting CD-20 for possible treatment of hematologic malignancies.

• Apple launched a mobile app to track quality of life of breast cancer survivors. Data will be used to study why some survivors recover faster than others, why symptoms vary, and what can be done to improve problems such as fatigue, mood and cognitive changes, and sleep disturbances. The app is part of Apple's ResearchKit, which is designed to expand participation in research studies.

• At the Endocrine Society's 97th annual meeting in San Diego, CA, researchers presented results of a phase II trial of sunitinib (Sutent; Pfizer) showing that 19 of 24 patients with advanced-stage differentiated thyroid cancer experienced either significant tumor shrinkage or stable disease. The median progression-free survival was 241 days. Sunitinib is approved for the treatment of renal cell carcinoma and imatinib-resistant gastrointestinal stromal tumors.

• Bloomberg Philanthropies and the Bill & Melinda Gates Foundation launched the Anti-Tobacco Trade Litigation Fund to help combat the tobacco industry's use of international trade agreements to threaten countries and prevent them from passing strong tobacco-control laws. The fund, established with $4 million from the organizations, will help low- and middle-income countries draft and defend tobacco-control laws.

• Two out of three people diagnosed with cancer will survive at least 5 years, according to a report published by the Centers for Disease Control and Prevention. The most common cancers continue to be prostate, female breast, lung and bronchus, and colon and rectum, the report noted. The full report, “Invasive Cancer Incidence and Survival—United States, 2011” is available at www.cdc.gov/mmwr.

For more news on cancer research, visit Cancer Discovery online at http://CDnews.aacrjournals.org.